Valuation (45%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.47 | 6.08 |
| PEG Ratio (TTM) | -0.63 | -0.37 |
| P/S Ratio (TTM) | 0.97 | 1.33 |
| P/B Ratio (TTM) | 0.53 | 1.60 |
| P/FCF Ratio (TTM) | -3.13 | 9.28 |
| Price to 5YR AVG Earnings Ratio | 7.12 | 3.77 |
| Price to 5YR AVG FCF Ratio | 35.37 | 10.19 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.65% | 13.62% |
| ROE (TTM) | -9.45% | 22.92% |
| Net Profit Margin (TTM) | -17.83% | 16.29% |
| ROIC 5YR AVG | 9.11% | 31.20% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -289.95% | 56.57% | 13.64% |
| Revenue | -2.52% | 14.87% | 11.90% |
| Net Income | -289.59% | 58.86% | 15.46% |
| Cash Flow | 34.75% | 1,001.26% | 594.94% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.82 | 2.94 |
| Quick Ratio (TTM) | 1.80 | 2.31 |
| D/E Ratio (TTM) | 0.16 | 0.15 |
| Interest Coverage (TTM) | -10.42 | 21.38 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 1.94 | 3.97 |
| LTL to 5YR AVG FCF | 3.82 | 0.91 |
| Shares Outstanding Growth 5YR AVG | 1.45% | 4.38% |